ArticleInternational journal of molecular sciences2026
Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.
Khuloud Bajbouj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.